Quintin J. Lai - 10 Sep 2021 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role: VP Corp Development & Strategy
Signature: Ryan Metz as Agent for Quintin J. Lai
Issuer symbol: WST
Transactions as of: 10 Sep 2021
Net transactions value: -$3,866,283
Form type: 4
Filing time: 14 Sep 2021, 10:45:01 UTC
Next filing: 24 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WST	Common Stock	Options Exercise	$517,198	+8,672	+388%	$59.64^*	10,906	10 Sep 2021	Direct
transaction	WST	Common Stock	Options Exercise	$72,970	+1,000	+9.2%	$72.97^*	11,906	10 Sep 2021	Direct
transaction	WST	Common Stock	Sale	$2,334,012	-5,072	-43%	$460.18	6,834	10 Sep 2021	Direct	F1
transaction	WST	Common Stock	Sale	$1,428,494	-3,100	-45%	$460.80	3,734	10 Sep 2021	Direct	F2
transaction	WST	Common Stock	Sale	$693,946	-1,500	-40%	$462.63	2,234	10 Sep 2021	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WST	Stock Option (Right to Buy)	Options Exercise	$0	-8,672	-100%	$0.000000^*	0	10 Sep 2021	Common Stock	8,672	$59.64	Direct
transaction	WST	Stock Option (Right to Buy)	Options Exercise	$0	-1,000	-100%	$0.000000^*	0	10 Sep 2021	Common Stock	1,000	$72.97	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $459.50 to $460.44, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F2	The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $460.50 to $461.44, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F3	The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $462.48 to $462.805, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.